NeoGenomics Inc. Common Stock vs Seaboard Corporation Common Stock — how do they compare? NeoGenomics Inc. Common Stock trades at $16.85 (market cap $2.14B), while Seaboard Corporation Common Stock trades at $4,019 (market cap $3.80B). The key difference: Seaboard Corporation Common Stock is the larger of the two by market cap, and Seaboard Corporation Common Stock pays a 0.23% dividend while NeoGenomics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold NeoGenomics Inc. Common Stock for 0 Days and Seaboard Corporation Common Stock for 0 Days on average.
| NEO | SEB | |
|---|---|---|
Market Cap | $2.14B | $3.80B |
Volume | 2,228,400 | 9,086 |
Sector | Health | Industrials |
52-Week High | $19.91 | $5.96K |
52-Week Low | $7.19 | $3.22K |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $2.44B | $4.57B |
Dividend Yield | — | 0.23% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
NeoGenomics, Inc. is a US cancer diagnostics company that provides genomic and pathology testing services, offering an oncology-focused testing menu used by oncologists, pathologists, and hospital systems across the cancer care continuum.
Read more on NEO →Seaboard Corporation is a diversified agribusiness and transportation company operating through pork production, commodity trading and milling, marine cargo shipping, liquid fuels, power generation, and turkey production segments, including its Seaboard Foods and Butterball businesses. It operates across North America, the Caribbean, South America, Africa, and Europe.
Read more on SEB →